RAC 2.42% $1.61 race oncology ltd

but out price, page-147

  1. 6,673 Posts.
    lightbulb Created with Sketch. 1676
    Great response and thinking by mgmt and BOD.

    Charlie Munger said that “the only job of the BOD is to deepen the moat”. Risk management is anyway the mgmt and BOD responsibility.

    Bisantrene trials deepens the moat and increases the value in the company. Mgmt is taking actions by building the team both internally and externally which mitigates the risk of what Dr.T has articulated above and in general regarding execution risk. We can clearly see that mgmt and BOD are doing everything possible to ensure success of trials and highest value realisation for the benefit of SH.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.61
Change
-0.040(2.42%)
Mkt cap ! $274.1M
Open High Low Value Volume
$1.65 $1.70 $1.60 $229.6K 139.7K

Buyers (Bids)

No. Vol. Price($)
1 129 $1.61
 

Sellers (Offers)

Price($) Vol. No.
$1.65 2839 1
View Market Depth
Last trade - 16.10pm 04/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.